Jump to section
To revolutionise drug discover and personalised care.
BC Platforms is a technology company offering a genomic data management platform for the development of personalised medicine approaches, accelerating the translation of insights into clinical practices. The platform is designed to support secure and efficient management, analysis, and interpretation of genomic data and provides a comprehensive solution for managing that data across the entire lifecycle, from sample collection to data analysis and reporting.
Alongside this, BC Platforms developed a Global Data Partner Network (BCRQUEST) which allows access to high-quality real-world data. This network has seen rapid growth and is now used across many sites, including a network of hospitals, and covers over 20 countries across the world, providing standard-of-care data for over 23M patients.
What began as an MIT Whitehead project in 1997 has since developed into strong scientific heritage over the past 25 years by working closely with a network of leading researchers, developers, and industry partners. BC Platforms now has operations globally and doesn't plan to slow down soon, instead, the company is focused on accelerating the expansion of its digital footprint to provide users of its services with more than 100M accessible subjects by 2026.
Steph
Company Specialist at Welcome to the Jungle
Nov 2022
$20m
GROWTH EQUITY VC
Dec 2019
$15m
SERIES C
Timo Kanninen
(CSO)In 1997 they created a database that could store and analyse genetic and phenotypic data together at MIT Whitehead Institute - this database became the foundation for BC Platforms.